1. D-Gdactosamine-HCI induces toxic hepatitis in the rat and was used as a model to study some aspects of iron metabolism during liver cell damage. Some changes in iron metabolism were similar to those encountered in human acute viral hepatitis.
Introduction
1. D-Gdactosamine-HCI induces toxic hepatitis in the rat and was used as a model to study some aspects of iron metabolism during liver cell damage. Some changes in iron metabolism were similar to those encountered in human acute viral hepatitis.
2. During the first 3 days of liver cell damage induced by galactosamine, liver depot iron and especially ferritin iron decreased by approximately 20%. Plasma ferritin rose, with a peak mean value which was approximately 20 times the concentration measured in normal rats. 3. During the acute phase, plasma ferritin did not accurately reflect the change in the level of liver depot iron.
4. During and after the acute phase, liver depot iron increased after an initial decrease. The non-ferritin depot iron fraction was elevated approximately 75% compared with the value in normal rats. This increase in non-ferritin iron was probably caused by increased erythrocyte catabolism in the liver and recapture followed by catabolism of liver ferritin that had leaked into the blood.
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Correspondence: Dr F. M. J. Zuyderhoudt It is known that during liver cell damage and necrosis (e.g. that encountered in viral hepatitis) the serum iron concentration (Peterson, 1952) and the serum ferritin concentration (Prieto, Barry 8c Sherlock, 1975) are often elevated. This is probably caused by release of iron and ferritin from disintegrated liver cells. The release of these compounds indicates that liver depot iron might decrease. In viral hepatitis in man a low depot iron concentration is sometimes found (Hengeveld, Zuyderhoudt & Van Gool, 1978; Zuyderhoudt, Hengeveld, Van Gool 8c Jorning, 1978a) . However, we could not compare these results with, values from a normal population because liver biopsy specimens from healthy people would be required. Accordingly, we have studied liver depot iron in rats, both during the acute phase of the toxic hepatitis and the following repair phase. To induce liver cell damage we used mgalactosamine-HCI. Galactosamine is known to influence several hepatic functions (Van Gool, Boers 8c De Nie, 1978) . Histological examination of liver slices revealed liver cell damage to be quite comparable with the kind of liver cell damage seen in human viral hepatitis (Medline, Schaffner 8c Popper,
1970).
We have also studied liver iron fractions and some indices of iron metabolism in the blood during 14 days after induction of the hepatitis in male rats.
Methods
Liver ferritin protein was measured by using a F. M. J. Zuyderhoudt et al.
radial immunodiffusion method (Zuyderhoudt, 1975) .
Ferritin iron and total tissue iron were measured after wet ashing (Zuyderhoudt, 1975; Zuyderhoudt, Van Gool & Jorning, 1977) . Haem iron was measured as the pyridine haemochromogen (Zuyderhoudt et al., 1977) .
This iron fraction, measured as haem, represents the haem from intracellular haem compounds in the liver. In rats with intrahepatic bleeding, haemoglobin-derived haem is included in the measured liver haem iron content.
The difference between total liver iron and the sum of haem iron and total ferritin iron represents the non-ferritin depot iron fraction (Zuyderhoudt, Jorning & Van Gool, 1978b) . Total liver depot iron is calculated as the difference between total liver iron and liver haem iron.
Plasma ferritin was measured by an enzymelinked immuno-assay (Zuyderhoudt, Boers, Linthorst, Jorning & Hengeveld, 1978~) .
Haemoglobm, packed cell volume, plasma iron, the total iron-binding capacity of plasma and plasma alanine aminotransferase (EC 2.6.1.2) were measured by standard clinical chemical methods.
Male Wistar rats (270-300 g) received 375 mg of D-galactosamine-HC1 in NaCl solution (154 mmol/l) intraperitoneally to induce acute hepatitis. Before the rats were killed they were kept overnight without food. To prevent hypoglycaemia during the fasting period the drinking water contained D-glucose (5 g/100 ml). During the first phase of the hepatitis liver swelling occurred. Therefore, instead of tissue concentrations, compounds are presented as amounts/whole liver. To remove the blood, livers were perfused in situ through the portal vein with NaCl solution (154 mmol/l). A part of the median lobe was used for histological identification of depot iron granules (haemosiderin). Liver slices were stained for iron with Perk stain.
Rats were killed at 0 and 6 h, and 1, 3, 7 and 14 days after galactosamine administration. Rats killed at 0 h were normal rats that had received NaCl solution (154 mmol/l) instead of galactosamine intraperitoneally.
Erythrocyte haemoglobin was labelled with s9Fe in donor rats by intravenous administration of 20-50 pCi of 59Fe ([s9Fe]ferric citrate; The Radiochemical Centre, Amersham, Bucks., U.K.). After 7 days the erythrocytes were labelled in vitro (ICSH-panel, 1971 ) with $ICr (sodium [Wrlchromate; The Radiochemical Centre). Ten normal rats were given these doubly labelled erythrocytes in an amount corresponding to 1 ml of rat blood. Subsequently six rats received galactosamine intraperitoneally and all were killed 3 days later.
In a following experiment four donor rats received intravenously 20-50 pCi of [59Felferric citrate. After 4 days two of the donor rats received galactosamine in NaCl solution (154 mmol/l) intraperitoneally and the other two donor rats received NaCl solution (154 mmol/l) intraperitoneally. Three days later the rats' erythrocytes were obtained after bleeding and separately labelled with approximately 50 pCi of sodium [Wrlchromate. Erythrocytes, corresponding to 1 ml of rat blood, from one rat were used to transfuse three normal rats, so six normal rats had received erythrocytes from two donors with galactosamineinduced hepatitis and six normal rats had received labelled erythrocytes from two normal donors.
Because of the small differences in liver accumulation of the radionuclides in the recipient rats, mean values were calculated per six rats with transfused 'normal' erythrocytes and per six rats with transfused 'hepatitis' erythrocytes. Of all 22 recipient rats 3 ml of liver homogenates and 0.5 ml of blood samples (diluted to 3 ml) were measured for their "Cr and 59Fe contents in a 5 inch well-type NaI(T1) crystal.
The energy windows of the spectrum analyser were adjusted in such a way as to exclude the %r photons from the 59Fe channel. The radioactivity counts collected in the %r channel were corrected for the contribution of the 59Fe photons. Standard deviation of the measurements was approximately 2%.
All points in the Figures are mean values with the SEM. Significances are calculated by use of Student's t-test (non-paired values).
Results
Total liver iron (Fig. 1) and the ferritin iron part of this fraction (Fig. 2a) decreased in the first 3 days, the acute phase, of the toxic hepatitis. After 1 week the ferritin iron fraction had recovered, reaching maximal values that were not significantly different from the mean value in the normal rats (P > 0.05).
We denote the period after the acute phase as the repair phase of the hepatitis.
ARer an initial decrease, the non-ferritin depot iron fraction increased between 1 and 3 days after galactosamine administration (Fig. 2b) . On day 7 this fraction was significantly higher (P < 0.001) than in the normal rats. The rapid decrease of liver depot iron could have been accompanied by loss of iron via the urine and the bile. However, 6 h after galactosamine, during the period of the lowest depot iron content of the liver, iron was not increased in the urine or the bile. The bile flow was not influenced by the hepatitis. The changes of the plasma ferritin protein concentration and of the liver ferrith protein content are shown in Fig. 3a and 36 . The plasma -1 L200 p. ferritin concentration paralleled plasma alanine aminotransferase activity. Three days after galactosamine the values had almost returned to normal.
The plasma ferritin concentration and the alanine aminotransferase activity at 24 h after galactosamine are very much higher than the values measured at 6 h. The liver ferritin protein content at 24 h was already increasing compared with the value at 6 h after galactosamine administration. The mean iron content of liver ferritin did not change significantly over 14 days. Fig. 4 shows that the plasma iron concentration and the percentage of transferrin saturation increased during the acute phase and remained increased until day 3. Then plasma alanine aminotransferase activities had reached almost normal values (Fig. 3a) .
Compared with the blood-haemoglobin concentration in the normal rats (9.0 mmol/l; SEM 0.2 mmol/l, n = S), the haemoglobin concentration on day 14 after galactosamine administration had decreased slightly but significantly (P < 0.05) to 8.4 mmol/l (SEM 0.2 mmol/l, n = 10).
In the acute phase haem iron in the liver homogenates had increased from 6 1 pg/liver in normal rats (SEM 6 pg/liver, n = 8) to 130 and 120 pg/liver at 6 h and 24 h respectively (SEM 20 and 16 pg/liver, n = 7 and 10 respectively; for both, P <
0.001).
On day 3 the haem iron content of the livers had returned almost to the values measured in normal rats. The difference was not significant (P > 0.05). On days 7 and 14 the liver haem iron content was the same as in normal rats.
The decrease of the blood-haemoglobin concentration, and the increased liver haem content during the acute phase, suggested that haemolysis was taking place. To study this we transfused rats with T r -and 59Fe-labelled erythrocytes. Significantly more T r and 59Fe was accumulated in the hepatitic livers than in the livers of control rats ( Table 1) . We investigated whether the increased liver accumulation of radioactivity in rats with hepatitis was caused by increased sequestration in macrophages of galactosamine-damaged erythrocytes. Normal rats were transfused with labelled erythrocytes from rats with hepatitis. However, galactosamine treatment of the rats did not damage the erythrocytes obviously, because no increased liver accumulation of radionuclides was measured.
Histological examination of liver slices showed that in the acute phase (24 h after treatment) the liver structure was clearly abnormal.
In this period no stainable iron, haemosiderin, could be detected. On day 3, however, and especially on day 7 after galactosamine treatment, some macrophages in the liver became positive on iron staining. On day 7 the liver structure had almost returned to normal, as far as can be detected by this method. lrderhoudt et al. 
Discussion
During the first 24 h of galactosamine-induced hepatitis, liver cell damage and leakage led to an increased plasma transaminase activity and raised plasma ferritin protein concentration (Fig. 3a) .
Because of ferritin release from the liver (Fig. 2a  and Fig. 3b) , liver depot iron decreased during the first 6 h after galactosamine administration (Fig. 1) . The mean iron content of the plasma ferritin during liver cell leakage was in the same range as in liver ferritin (preliminary results). The iron content of plasma ferritin during the acute phase of the hepatitis, combined with the similar changes of the plasma transaminase activity and the plasma ferritin concentration during these experiments (Fig. 3a) indicated that the transient increase of the plasma ferritin concentration was caused by liver cell leakage.
About 6 h after galactosamine administration the iron concentrations in the bile and the urine were equal to those in normal rats. So in this period there was no increased iron release from the body.
From 6 to 24 h after galactosamine administration the situation became complex. Liver depot iron and liver ferritin started to increase (Figs. 1,2a  and 3b) , and plasma ferritin concentration increased as well (Fig. 3a) . In this period changes in the plasma ferritin concentration did not reflect the change in liver depot iron.
The increased liver haem concentration, and the erythrocyte sequestration (Table l), indicated that haemolysis had occurred. The increased erythrocyte sequestration was not caused by galactosamine-induced erythrocyte damage followed by liver macrophage capture, but by small intrahepatic haemorrhage. During the first 24 h of the toxic hepatitis, petechiae on the liver surface and in the liver could be seen regularly.
After an initial decrease, liver depot iron fractions started to increase ( Figs. 1 and 2) . Part of the iron of the intrahepatic sequestered haemoglobin was incorporated into ferritin. On day 3 after galactosamine administration and transfusion of the labelled erythrocytes, the specific 59Fe radioactivity of liver ferritin increased to three times the value of that for control rats. Increased haemoglobin catabolism also results in increased liver ferritin concentration (Zuyderhoudt et al., 1977) . Liver ferritin is known to be taken up from the plasma by the liver. After uptake into the parenchymal cells ferritin is catabolized rapidly. Part of this iron is incorporated in ferritin synthesized de novo (Unger & Hershko, 1974 ). Thus we conclude that catabolism of the extravasated blood, and recapture in the liver of ferritin that had leaked to the plasma, were the primary causes of the increase in the liver depot iron fractions.
During the repair phase of the toxic hepatitis, total liver depot iron increased; the increase was less than 25%. This grade of siderosis is minor compared with the accumulation of iron in the livers of patients with profound iron-loading diseases (Barry & Sherlock, 1971) . The increase of liver depot iron was primarily caused by the increase of the non-ferritin depot iron fraction. As we have shown earlier, haemoglobin catabolism as well as intrahepatic catabolized liver ferritin sequestered from the plasma can provide nonferritin iron (Zuyderhoudt et al., 1977 (Zuyderhoudt et al., , 1978b .
The low grade of iron loading was confirmed by histological examination of liver slices.
During the repair phase, liver macrophages contained haemosiderin granules, suggesting a relationship between haemosiderin and the nonferritin depot iron, although these fractions are not identical (Zuyderhoudt et al., 1978b) .
In man, spotty deposition of iron-positive material in the liver during the repair phase of acute viral hepatitis has been observed (Wepler & Opitz, 1958) .
Serum iron remained elevated during the repair phase just as in human hepatitis, whereas plasma ferritin had already declined to normal concentrations. It seems likely that part of the newly formed depot iron, built up in the first 3 days, is transferred gradually from the liver to the blood, contributing to the raised plasma iron concentration (Fig. 4) . Possibly the high plasma iron concentration reflected catabolism of extravasated blood.
The decrease of liver depot iron during the acute phase of the toxic hepatitis was soon followed by an increase, though the grade of haemosiderosis was low. The non-ferritin depot iron fraction accounted for the greatest part of this increase and was primarily due to minor intrahepatic bleeding and recapture followed by catabolism of liver ferritin that had leaked into the blood. During the acute phase, plasma ferritin did not accurately reflect the change in the amount of liver depot iron.
In conclusion, galactosamine hepatitis in the rat is ti model that can be used to study iron metabolism during acute liver cell damage and necrosis.
